PLDT Inc. PHI
17.20
(0.25)
(1.43%)
as of 25 Sep
- Market cap
- $3.8B
- P/E
- 8.1×
Follow PHI
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
7.89 | 9.38 | 9.16 | 8.27 |
P/S ratio |
1.06 | 1.24 | 1.19 | 1.01 | |
P/FCF ratio |
12.19 | 7.51 | 6.87 | 5.07 | |
P/Operating CF |
8.19 | 11.98 | 11.75 | 10.42 | |
P/B ratio |
1.91 | 2.12 | 2.11 | 1.72 | |
Price to Tangible BV |
4.09 | 4.27 | 4.30 | 3.29 | |
EV/Sales |
2.37 | 2.53 | 2.45 | 2.26 | |
EV/EBITDA |
4.62 | 5.23 | 5.07 | 4.78 | |
EV/Operating CF |
5.80 | 5.60 | 5.54 | 5.18 | |
EV/FCF |
27.29 | 15.38 | 14.07 | 11.34 | |
Quick Ratio |
0.25 | 0.27 | 0.26 | 0.28 | |
Current Ratio |
0.38 | 0.44 | 0.42 | 0.44 | |
Net Debt/EBITDA |
10.84 | 13.12 | 9.36 | 11.02 | |
Debt/Assets |
47.26% | 46.48% | 46.20% | 46.68% | |
Debt/Equity |
2.45 | 2.30 | 2.32 | 2.20 | |
Asset Turnover |
0.35 | 0.35 | 0.35 | 0.35 | |
Operating CF/Net income |
4.08 | 6.76 | 2.57 | 2.93 | |
Capex/Depreciation |
(1.01) | (0.53) | (0.74) | (0.69) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 105.90% | 32.21% | 0.00% | |
Intangible Assets out of Total Assets |
0.10 | 0.10 | 0.10 | 0.10 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(1.93) | (1.62) | (1.64) | (1.85) | |
Graham Number |
22.83 | 23.15 | 22.70 | 22.04 | |
Earnings Yield |
12.67% | 10.66% | 10.92% | 12.09% | |
Free Cash Flow Yield |
8.21% | 13.31% | 14.56% | 19.72% | |
Revenue per Share |
4.34 | 4.34 | 4.45 | 4.21 | |
Operating CF per Share |
2.28 | 1.82 | 1.79 | 1.68 | |
Capex per Share |
(1.35) | (0.80) | (0.89) | (0.78) | |
Free Cash Flow per Share |
0.94 | 1.02 | 0.90 | 0.90 | |
Cash per Share |
0.88 | 0.97 | 1.18 | 0.92 | |
Shareholders Equity per Share |
9.82 | 10.32 | 10.01 | 10.24 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
9.82 | 10.32 | 10.01 | 10.24 | |
Free Cash Flow |
202.95 | 219.71 | 193.53 | 195.22 | |
Working Capital |
(1,775.15) | (1,561.30) | (1,787.97) | (1,542.49) | |
Capital Expenditures |
(291.58) | (172.45) | (193.24) | (168.74) | |
Net Current Asset Value |
(7,807.08) | (7,609.58) | (7,441.17) | (7,029.35) | |
EV/EBIT |
11.02 | 13.27 | 13.25 | 12.92 | |
Capex to Sales |
0.31 | 0.18 | 0.20 | 0.19 | |
Net Profit Margin |
12.91% | 6.19% | 15.69% | 13.65% | |
Price to Operating Income |
4.92 | 6.48 | 6.47 | 5.78 | |
| Other line items | |||||
Average Receivables |
512.85 | 549.50 | 545.48 | 568.04 | |
Average Payables |
1,137.35 | 1,074.31 | 975.81 | 974.97 | |
Average Inventory |
36.37 | 44.96 | 43.55 | 44.86 | |
Average Assets |
10,933.57 | 10,976.66 | 10,856.90 | 10,837.49 | |
Average Common Equity |
2,042.28 | 2,126.85 | 2,082.47 | 2,215.43 |
Columns are period end dates